Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail.
Open forum infectious diseases
Juarez-Reyes, M., Gallivan, M., Chyorny, A., O'Keeffe, L., Shah, N. S.
2016; 3 (1): ofv220-?
Abstract
In an urban jail population, 3 months of isoniazid and rifapentine (3HP) was associated with an 85% latent tuberculosis infection treatment completion rate compared with 18% in a standard 9-month isoniazid treatment group. Among the 91 patients who started 3HP therapy, there were 2 treatment discontinuations from adverse drug reactions.
View details for DOI 10.1093/ofid/ofv220
View details for PubMedID 26885547
View details for PubMedCentralID PMC4753347
